Sunday, November 22, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Tilray Shares Retreat Following Brief Trump-Inspired Rally

Andreas Sommer by Andreas Sommer
October 2, 2025
in Analysis, Cannabis, Trading & Momentum
0
Tilray Stock
0
SHARES
117
VIEWS
Share on FacebookShare on Twitter

Tilray’s stock experienced a significant pullback on Wednesday, declining 4.6% to $1.66 with a downward gap opening. This retreat comes just days after the cannabis company’s shares had surged dramatically in response to former President Donald Trump’s endorsement of CBD products.

Market Reality Sets In After Initial Euphoria

The previous Monday had seen Tilray shares explode with a remarkable 60.87% gain after Trump used his Truth Social platform to promote CBD as revolutionary for senior health. The former president characterized hemp-based CBD as a viable alternative to prescription medications—a declaration that sent shockwaves through the entire cannabis sector.

However, this market enthusiasm proved short-lived as profit-taking emerged among investors. Wednesday’s downward gap indicates substantial institutional selling pressure, with trading volume exceeding 160 million shares—more than double the 65-day average of 66.31 million shares.

Earnings Report Looms

The heightened volatility coincides with the approaching earnings release scheduled for October 9 at 8:30 AM Eastern Time. Tilray will disclose its first-quarter financial results for fiscal year 2026 during this event.

Market experts have established the following expectations:
– Loss per share: -$0.03 (representing a 25% improvement year-over-year)
– Revenue: $206.83 million (a 3.39% increase compared to the same period last year)
– Annual revenue forecast: $877.28 million (projecting 6.81% growth)

Should investors sell immediately? Or is it worth buying Tilray?

European Expansion Progresses

Just one day before the stock’s decline, Tilray had announced positive developments in the German market. The company is expanding its premium cannabis production capabilities at its EU-GMP certified facility in Neumünster. Under Germany’s BfArM cultivation program, five new cannabis flower products will join the Tilray Craft portfolio.

This European expansion underscores Tilray’s strategic focus on international medical cannabis markets, where regulatory frameworks tend to be more stable than the evolving landscape in the United States.

Political Uncertainty Continues to Drive Volatility

Despite recent weakness, Tilray shares maintain a 34.06% monthly gain. However, Monday’s 52-week high of $1.86 has already been erased as the stock retreated.

The cannabis industry remains heavily influenced by political developments. Trump’s CBD comments initially fueled speculation about potential federal reclassification of cannabis, though concrete policy changes have yet to materialize. Institutional skepticism persists, reflected in a short interest representing 14.06% of tradable shares.

Tilray’s path to sustained profitability remains challenging, with significant cash burn and potential dilution risks continuing to cloud the company’s long-term outlook.

Ad

Tilray Stock: Buy or Sell?! New Tilray Analysis from November 22 delivers the answer:

The latest Tilray figures speak for themselves: Urgent action needed for Tilray investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from November 22.

Tilray: Buy or sell? Read more here...

Tags: Tilray
Andreas Sommer

Andreas Sommer

About Andreas Sommer Over 40 years of expertise in market analysis, chart technical analysis, and strategic investment advisory. With more than four decades of experience in banking and financial journalism, Andreas Sommer is recognized as one of the leading analysts in the German-speaking market. His deep understanding of market dynamics and technical analysis has helped countless investors navigate complex financial markets.
Areas of Expertise:
  • Technical Chart Analysis
  • Strategic Investment Advisory
  • Market Trend Analysis
  • Financial Journalism
Andreas brings unparalleled insights from his extensive career in banking and financial markets, making him a trusted voice for investors seeking professional guidance.

Related Posts

SAP Stock
Analysis

SAP’s Buyback Machine Grinds On, But the Analyst Chorus Is Turning Sour

September 7, 2026
Münchener Rück Stock
Analysis

Munich Re’s Monte Carlo Warning Collides With Wall Street’s Widest Analyst Split in Years

September 7, 2026
Novo Nordisk Stock
Analysis

Novo Nordisk Faces a New Front: 300-Fold Rise in GLP-1 Scripts for Children Under 12

September 7, 2026
Next Post
Coca-Cola Stock

Coca-Cola Faces Dual Challenges Amid Analyst Praise and Tax Dispute

Microsoft Stock

Microsoft's Strategic Pivot: Leadership Reshuffle and New AI Subscription Target Mass Market

Micron Stock

Memory Chip Demand Surges as AI Revolution Intensifies

Recommended

WM stock news

Spire Wealth Management Shows Confidence in Churchill Downs Incorporated with New Acquisition and Bet on Future Growth

3 years ago
Chevron Stock

Chevron Shares Surge Amid Global Oil Supply Disruption

8 months ago
Q2 Holdings Stock

Inclusion in S&P SmallCap 600 Index Ignites Q2 Holdings Stock Rally

1 year ago
REV Stock

REV Group Shares Hit Record High Amid Political Scrutiny

1 year ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum DroneShield Eli Lilly FALLBACK Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Robinhood Rocket Lab USA Salesforce Strategy Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Nvidia Posts a Record Quarter, but Rate-Hike Fears Still Set the Tone

Home Depot Beats, Shares Slip: Bigger Tickets, Fewer Customers

Rotation, Not Panic: Retailers Test Where Tech’s Money Went

At 5.15%, the 10-Year Treasury Picks the Winners

Bitcoin Slips Below $70,000, and a Samsung Rumor Lifts Modine

Huang Exits, Cisco Reports: Who Actually Gets Paid for AI

Trending

CrowdStrike Stock
Newsletter

93% of Stocks Fall as CrowdStrike Courts Zscaler

by Stephanie Dugan
November 21, 2026
0

Dear readers, The question heading into Friday was whether Anthropic would hold its $83 offer price. It...

Nvidia Stock

Anthropic Lists at a Premium, but the Sell-Off Keeps Going

November 20, 2026
Bitcoin Stock

Anthropic’s $81 Billion IPO Meets a Market in Need of Good News

November 19, 2026
Nvidia Stock

Nvidia Posts a Record Quarter, but Rate-Hike Fears Still Set the Tone

November 18, 2026
Home Depot Stock

Home Depot Beats, Shares Slip: Bigger Tickets, Fewer Customers

November 17, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • 93% of Stocks Fall as CrowdStrike Courts Zscaler
  • Anthropic Lists at a Premium, but the Sell-Off Keeps Going
  • Anthropic’s $81 Billion IPO Meets a Market in Need of Good News

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com